Monday, 15 August 2016
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
Di Yu, Eric Morand,
et al
. published in
Nature Medicine.
Read article
here
.
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment